The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Therapeutic Radionuclides: Biophysical and Radiobiologic Principles
Open accessAbstract
Although the general radiobiologic principles underlying external beam therapy and radionuclide therapy are the same, there are significant differences in the biophysical and radiobiologic effects from the two types of radiation. In addition to the emission of particulate radiation, targeted radionuclide therapy is characterized by (i) extended exposures and, usually, declining dose rates; (ii) nonuniformities in the distribution of radioactivity and, thus, absorbed dose; and (iii) particles of varying ionization density and, hence, quality. This chapter explores the special features that distinguish the biologic effects consequent to the traversal of charged particles through mammalian cells. It also highlights what has been learned when these radionuclides and radiotargeting pharmaceuticals are used to treat cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS
Wambersie, A. (2004) · Journal of the ICRU · doi:10.1093/jicru/ndh019 · Cited by 869
Azzam, E. I. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011417098 · Cited by 589
Tumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Narayanan, P. K., Goodwin, E. H., & Lehnert, B. E. (1997) · PubMed · Cited by 461
Factors underlying the cell growth-related bystander responses to alpha particles.
Iyer, R. S., Lehnert, B. E., & Svensson, R. (2000) · PubMed · Cited by 355
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
McDevitt, M. R., Barendswaard, E., Ma, D., Lai, L. T., Curcio, M. J., Sgouros, G., Ballangrud, Å., Yang, W., Finn, R. D., Pellegrini, V., et al. (2000) · PubMed · Cited by 259
Axworthy, D. B., Reno, J. M., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F.-M., Hobson, L. J., Beaumier, P. L., & Fritzberg, A. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1802 · Cited by 230
Bystander effect produced by radiolabeled tumor cells in vivo
Xue, L. Y., Butler, N. J., Makrigiorgos, G. M., Adelstein, S. J., & Kassis, A. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182209699 · Cited by 198
Self-citationCostantini, D. L., Chan, C., Cai, Z., Vallis, K. A., & Reilly, R. M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037937 · Cited by 190
Cited by
Rasheed, R., Usmani, S., Raza Naqvi, S., Alkandari, F., & Marafi, F. (2019) · Indian Journal of Nuclear Medicine · doi:10.4103/ijnm.ijnm_115_18 · Cited by 11
Metadata
- Authors
- Kassis, A. I.
- Venue
- Seminars in Nuclear Medicine
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 38
- Issue
- 5
- Pages
- 358-366
- ISSN
- 0001-2998 (ISSN-L)
- OpenAlex
- W2094108414
- Cited by
- 306
- References
- 23
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic Radionuclides: Biophysical and Radiobiologic Principles. https://app.cochat.ai/papers/10.1053/j.semnuclmed.2008.05.002
- The paper
- Kassis, A. I. (2008). Therapeutic Radionuclides: Biophysical and Radiobiologic Principles. Seminars in Nuclear Medicine. https://doi.org/10.1053/j.semnuclmed.2008.05.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
